COLUMN GROUP IV GP, LP purchased 2.12M shares of EIKON THERAPEUTICS, INC. on the open market
Open‑market purchase worth $38.12M. The strongest form of insider conviction signal.
Common Stock
Shares
+1.30M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+1.40M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+110.93K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+44.25K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+47.90K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+3.79K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+688.28K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+1.44M
Price / share
$18.00
Trade value
$25.87M
% of position
Common Stock
Shares
+49.56K
Price / share
$18.00
Trade value
$892.01K
% of position
Common Stock
Shares
+630.88K
Price / share
$18.00
Trade value
$11.36M
% of position
Net shares
+5.71M
Net value
$38.12M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/6/2026 | C · Conversion | +1.30M | — | — | 2035.8% | 63.69K | 1.36M |
| Common Stock Indirect | 2/6/2026 | C · Conversion | +1.40M | — | — | 103.2% | 1.36M | 2.76M |
| Common Stock Indirect | 2/6/2026 | C · Conversion | +110.93K | — | — | 4.0% | 2.76M | 2.87M |
| Common Stock Indirect | 2/6/2026 | C · Conversion | +44.25K | — | — | 1320.1% | 3.35K | 47.60K |
| Common Stock Indirect | 2/6/2026 | C · Conversion | +47.90K | — | — | 100.6% | 47.60K | 95.50K |
| Common Stock Indirect | 2/6/2026 | C · Conversion | +3.79K | — | — | 4.0% | 95.50K | 99.28K |
| Common Stock Indirect | 2/6/2026 | C · Conversion | +688.28K | — | — | New position | 0.00 | 688.28K |
| Common Stock Indirect | 2/6/2026 | P · Purchase | +1.44M | $18.00 | $25.87M | 50.0% | 2.87M | 4.31M |
| Common Stock Indirect | 2/6/2026 | P · Purchase | +49.56K | $18.00 | $892.01K | 49.9% | 99.28K | 148.84K |
| Common Stock Indirect | 2/6/2026 | P · Purchase | +630.88K | $18.00 | $11.36M | 91.7% | 688.28K | 1.32M |
| Total | +5.71M | $38.12M | ||||||
Series A Preferred Stock
Common Stock
1.30M shares
Shares
−9.67M
Strike price
Held after
0.00
Exercisable
—
Series A Preferred Stock
Common Stock
44.25K shares
Shares
−330K
Strike price
Held after
0.00
Exercisable
—
Series A-1 Preferred Stock
Common Stock
1.40M shares
Shares
−10.47M
Strike price
Held after
0.00
Exercisable
—
Series A-1 Preferred Stock
Common Stock
47.90K shares
Shares
−357.22K
Strike price
Held after
0.00
Exercisable
—
Series C-1 Preferred Stock
Common Stock
110.93K shares
Shares
−827.28K
Strike price
Held after
0.00
Exercisable
—
Series C-1 Preferred Stock
Common Stock
3.79K shares
Shares
−28.23K
Strike price
Held after
0.00
Exercisable
—
Series D Preferred Stock
Common Stock
688.28K shares
Shares
−5.13M
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Indirect | Common Stock1.30M shares | 2/6/2026 | C · Conversion | −9.67M | — | 0.00 | |
| Series A Preferred Stock Indirect | Common Stock44.25K shares | 2/6/2026 | C · Conversion | −330K | — | 0.00 | |
| Series A-1 Preferred Stock Indirect | Common Stock1.40M shares | 2/6/2026 | C · Conversion | −10.47M | — | 0.00 | |
| Series A-1 Preferred Stock Indirect | Common Stock47.90K shares | 2/6/2026 | C · Conversion | −357.22K | — | 0.00 | |
| Series C-1 Preferred Stock Indirect | Common Stock110.93K shares | 2/6/2026 | C · Conversion | −827.28K | — | 0.00 | |
| Series C-1 Preferred Stock Indirect | Common Stock3.79K shares | 2/6/2026 | C · Conversion | −28.23K | — | 0.00 | |
| Series D Preferred Stock Indirect | Common Stock688.28K shares | 2/6/2026 | C · Conversion | −5.13M | — | 0.00 |